首页 >
法规速递
-
Cancer Clinical Trial Eligibility Criteria: Laboratory Values-2026/7/27
2026-07-28查看详情 > -
Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications-2026/7/27
2026-07-28查看详情 > -
Cancer Clinical Trial Eligibility Criteria: Performance Status-2026/7/27
2026-07-28查看详情 > -
Hemodialysis Blood Tubing Sets - Premarket Notification (510(k)) Submissions-2026/7/23
2026-07-24查看详情 > -
Formal Meetings Between the Food and Drug Administration and Sponsors or Requestors of Over-the-Counter Monograph Drugs-2026/7/14
2026-07-15查看详情 > -
Topical Dermatologic Corticosteroids: In Vivo Bioequivalence-2026/7/14
2026-07-15查看详情 > -
Psychedelic Drugs: Considerations for Clinical Investigations-2026/7/14
2026-07-15查看详情 > -
Submitting Next-Generation Sequencing Data to the Division of Antiviral Products-2026/7/1
2026-07-02查看详情 > -
Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus-2026/6/29
2026-06-30查看详情 > -
Master Protocols for Drug and Biological Product Development-2026/6/24
2026-06-24查看详情 >